In addition to the widely appreciated role of activated RAS driving cancer cell signaling through binding to effector proteins such as the serine/threonine‐protein kinase, RAF, which can activate the mitogen activated protein kinase (MAPK) cell signaling pathway to drive cancer cell proliferation, constitutively activated RAS is also now recognized to suppress the body's natural defense mechanisms of immune surveillance.10 Here, WNK2 is linked to cancer.